Table 3.

Results of multivariable analysis of risk factors for regression of genital warts.

		Hazard Ratio (HR)	95% Lower CL	95% Upper CL	p-value
CD4+ by HIV Viral Load	HIV− (ref)	1.00
	CD4>500, VL<=4,000	0.79	0.52	1.22	0.29
	CD4>500, VL: 4,001–20,000	0.72	0.41	1.25	0.24
	CD4>500, VL: 20,001–100,000	0.63	0.36	1.09	0.10
	CD4>500, VL>100,000	0.68	0.15	2.95	0.60
	CD4:200–500, VL<=4,000	0.73	0.48	1.11	0.14
	CD4:200–500, VL: 4,001–20,000	0.60	0.38	0.95	0.03
	CD4:200–500, VL: 20,001–100,000	0.78	0.49	1.23	0.28
	CD4:200–500, VL>100,000	0.69	0.41	1.18	0.18
	CD4<200, VL<=4,000	0.63	0.40	0.99	0.047
	CD4<200, VL: 4,001–20,000	0.40	0.24	0.68	0.001
	CD4<200, VL: 20,001–100,000	0.46	0.28	0.73	0.001
	CD4<200, VL>100,000	0.37	0.23	0.59	<.0001
Age	<30 (ref)
	30–34	1.09	0.82	1.44	0.55
	35–39	1.37	1.06	1.77	0.02
	40–44	0.98	0.71	1.34	0.89
	>45	1.18	0.89	1.56	0.24